Clinical Trial: Study on the Tolerability and Pharmacokinetics of HX009 in Patients With Advanced Solid Tumors
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition: Advanced Solid Tumors
Study Type: Interventional
Official Title: Phase I Clinical Trial of Tolerability and Pharmacokinetics of HX009 in Patients With Advanced Solid Tumors
Brief Summary:
This is an open, multi-dose administration dose exploratory clinical phase I study to evaluate the safety, tolerability, and PK characteristics of HX009 injection in patients with advanced solid tumors and to initially measure its antitumor efficacy.
Read more